
Loading, please wait...

Loading, please wait...

Digital health tools are transforming patient care by providing data-driven insights into lifestyle habits. Currently, the private equity owner of MyFitnessPal is exploring a sale that could value the app at over $1 billion. Francisco Partners is reportedly working with JPMorgan to manage the process. This news highlights the massive financial growth within the health technology sector.
The adoption of nutrition and fitness applications has surged globally. MyFitnessPal, founded in 2005, now boasts over 280 million members. It helps users track calories, vitamins, and exercise. Consequently, healthcare providers increasingly utilize these data points to support clinical outcomes in chronic disease management. Patients benefit from the premium features, such as on-demand video workouts and personalized meal plans.
Furthermore, the shift towards digital integration allows for better patient engagement. Platforms like MyFitnessPal, Strava, and Oura rings provide real-time insights that were previously unavailable. Because of this, the market for digital health tools continues to attract significant investment and valuation. Additionally, the potential sale signifies a broader trend of consolidation in digital wellness. This synergy creates a robust ecosystem for monitoring patient health outside of clinical settings.
Q1: What is the current valuation of MyFitnessPal?
Sources indicate that the sale could value the application at over $1 billion.
Q2: Who currently owns the MyFitnessPal application?
Francisco Partners, a technology-focused investment firm, currently owns the platform after acquiring it from Under Armour in 2020.
Q3: How many users does MyFitnessPal have globally?
The company reported having over 280 million members across 120 different countries as of last year.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Private equity firm Francisco Partners explores a $1 billion sale of MyFitnessPal, highlighting the booming global demand for digital health tools....
6 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today